WSAW NewsChannel 7  | Central WI, Wausau, Rhinelander  |  News, Weather, Sports

FDA Approves Onyx Blood Cancer Drug Krypolis

By: Associated Press
By: Associated Press

WASHINGTON (AP) -- The Food and Drug Administration is approving a new blood cancer drug from Onyx Pharmaceuticals Inc. for patients whose disease has not responded to at least two other drugs.

Krypolis treats multiple myeloma, a form of cancer that causes tumors in the bone marrow and prevents the production of normal blood cells. Patients with the disease have low red blood cell counts and are more likely to experience infections and excessive bleeding.

The FDA approved the drug based on a study showing 23 percent of patients experienced a full or partial disappearance of their tumor after taking the drug. The effect typically lasted about 7.8 months.

About 21,700 people will be diagnosed with multiple myeloma this year and 10,710 will die from the disease, according to the American Cancer Society.


Join the Conversation!

To comment, the following rules must be followed:

  • No Obscenity, Profanity, Vulgarity, Racism or Violent Descriptions
  • No Negative Community Comparisons
  • No Fighting, Name-calling, or Personal Attacks
  • Multiple Accounts are Not Allowed
  • Stay on Story Topic

Comments may be monitored for inappropriate content, but the station is under no legal obligation to do so.
If you believe a comment violates the above rules, please use the Flagging Tool to alert a Moderator.
Flagging does not guarantee removal.

Multiple violations may result in account suspension.
Decisions to suspend or unsuspend accounts are made by Station Moderators.
Questions may be sent to comments@wsaw.com.
Please provide detailed information.
All comments must adhere to the WSAW.com discussion rules.

powered by Disqus
WSAW-TV 1114 Grand Ave. Wausau, WI 54403
Gray Television, Inc. - Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 163193646 - wsaw.com/a?a=163193646